Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divis Laboratories Ltd reported Revenues for Q2FY24 of ₹1,909.00 Crores up from ₹1,855.00 Crore year on year, a rise of 2.91%.
Total Expenses for Q2FY24 of ₹1,526.00 Crores up from ₹1,320.00 Crores year on year, a rise of 15.61%.
Consolidated Net Profit of ₹348.00 Crores down 29.41% from ₹493.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.11, down 29.40% from ₹18.57 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.